Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...

Anna Podolanczuk, M.D., M.S., discusses how key epidemiological trends in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including changes in incidence and prevalence, ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Cardiomyopathies currently have no cures, but many of these disorders are prime candidates for gene therapies. Treatments for ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with widespread misinformation about treatment options, create significant barriers ...

Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...

The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...